2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice…
By B. J. Gersh, B. Maron, R. Bonow, J. Dearani, M. Fifer, Mark S. Link, S. Naidu, Rick A. Nishimura, Steve R. Ommen, H. Rakowski and 4 more. Journal of Thoracic and Cardiovascular Surgery, 2011
848 citations recorded by the source corpus.
Bernard J. Gersh, MB, ChB, DPhil, FACC, FAHA, Co-Chair*†; Barry J. Maron, MD, FACC, Co-Chair*†; Robert O. Bonow, MD, MACC, FAHA‡; Joseph A. Dearani, MD, FACC§ ; Michael A. Fifer, MD, FACC, FAHA*†; Mark S. Link, MD, FACC, FHRS*¶; Srihari S. Naidu, MD, FACC, FSCAI*#; Rick A. Nishimura, MD, FACC, FAHA†; Steve R. Ommen, MD, FACC, FAHA†; Harry Rakowski, MD, FACC, FASE†**; Christine E. Seidman, MD, FAHA†; Jeffrey A. Towbin, MD, FACC, FAHA††; James E. Udelson, MD, FACC, FASNC‡‡§§; Clyde W. Yancy, MD, FACC, FAHA
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/f153bcd6b6caa9fd458ca3f1d53141e1f5558107
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy ACCF/AHA 2011 (12)”
- Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014, methodology): “The capability to prospectively identify patients who will progress to the end stage is clinically relevant by permitting anticipation of changes in clinical course and management strategies, including tailored drug administration and early consideration for heart transplantation and prophylactic de”